Document is current
Any future updates will be listed below
-
Authors
Liu, Ying
Xu, Pengbiao https://orcid.org/0000-0003-0098-8875
Rivara, Sophie https://orcid.org/0000-0001-8341-5348
Liu, Chong https://orcid.org/0000-0001-6853-9625
Ricci, Jonathan https://orcid.org/0000-0002-1326-166X
Ren, Xuefeng https://orcid.org/0000-0002-4822-4316
Hurley, James H. https://orcid.org/0000-0001-5054-5445
Ablasser, Andrea https://orcid.org/0000-0002-8475-8999
- License Information
-
More Information
Article History
Received: 17 February 2022
Accepted: 15 September 2022
First Online: 19 October 2022
Competing interests
: A.A. is a scientific co-founder of IFM Due. J.H.H. is a co-founder and shareholder of Casma Therapeutics and receives research funding from Casma Therapeutics, Genentech and Hoffman-La Roche. The remaining authors declare no competing interests.
